MedTrace Logo

Mobile Individual Atrial Fibrillation Management Program

NCT06933615 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-04-18

No results posted yet for this study

Summary

The aim of the study is to develop a mobile individual atrial fibrillation management (m-BAFY) program and to evaluate the effects of the program on symptom severity, medication compliance, self-care agency and quality of life. The main questions that the study aims to answer are as follows;

* Is the m-BAFY program effective in symptom control?
* Is the m-BAFY program effective in increasing medication compliance?
* Is the m-BAFY program effective in improving self-care agency?
* Is the m-BAFY program effective in improving quality of life? In order to measure whether m-BAFY is effective, the researchers will download this application to one group's phones, and the other group will not download the application.

Participants;

* Use this application for 3 months
* Patients in the intervention group use the application at least once every two weeks.
* Fill in the symptom diary in the application.
* Clinical interviews are called for the first interview, at the end of the 1st month and at the end of the 3rd month.

Conditions

  • Atrial Fibrillation (AF)

Interventions

OTHER

Training prepared with mobile application

The m-BAFY program will be loaded onto the mobile phones of patients in the mobile application group. Each patient will be informed on how to use the mobile program. In addition, a short training will be given on how to use the application. With this application, the symptoms and vital signs recorded by the patients will be monitored and individual feedback will be provided. Information on the management of the disease prepared in line with the guidelines is included.

Sponsors & Collaborators

  • Ege University Hospital (Application and Research Center)

    collaborator UNKNOWN

  • Ege University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-10
Primary Completion
2025-01-15
Completion
2025-04-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06933615 on ClinicalTrials.gov